Editorial: Pharmacogenetics of psychiatric disorders

Editorial: Pharmacogenetics of psychiatric disorders

Saved in:

Bibliographic Details
Main Authors:	Sarah Allegra, Silvia De Francia, Stefano Comità, Maria Grazia Morgese, Thomas M. Polasek
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Genetics
Subjects:	pharmacogenomic (PGx) research pharmacogenomic antidepresants major depressive disorder cocaine drug abuse
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2024.1523071/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Analysis of depression in Brazil and the feasibility of incorporating pharmacogenomics as an auxiliary tool in antidepressant treatment
by: Rafaela Slaviero Pinheiro Cerdeira, et al.
Published: (2025-01-01)

Editorial: Insights in pharmacogenetics and pharmacogenomics: 2023
by: José A. G. Agúndez, et al.
Published: (2025-01-01)

Association between CYP2C19 polymorphism and proton pump inhibitors adverse drug reactions: a narrative review
by: Asmaa Ibrahim, et al.
Published: (2025-02-01)

Optimization of antidepressant treatment by pharmacogenomics: a case report
by: Ying Zhang, et al.
Published: (2025-01-01)

Stryphnodendron adstringens have a modulatory effect on inflammatory cytokines markers of in vitro activated macrophages
by: Ivana Beatrice Mânica da Cruz, et al.
Published: (2024-05-01)

Utility of Integrated Analysis of Pharmacogenomics and Pharmacometabolomics in Early Phase Clinical Trial: A Case Study of a New Molecular Entity
by: Jaeseong Oh, et al.
Published: (2018-09-01)

Integrating pharmacogenetics, multi‐omics and machine learning in the novel therapeutic view of pulmonary hypertension
by: Chenxi Li, et al.
Published: (2025-01-01)

Pharmacometabolomics Enables Real-World Drug Metabolism Sciences
by: Fleur B. Nijdam, et al.
Published: (2025-01-01)

Drug-induced lupus
by: Kavadichanda Chengappa G
Published: (2019-01-01)

Hypothesized pharmacogenomic and medication influences on tetrahydrocannabinol and cannabidiol metabolism in a cohort of unselected oral cannabis users
by: Jessica A. Wright, et al.
Published: (2025-01-01)

Pharmacogenomics Tools for Precision Public Health and Lessons for Low- and Middle-Income Countries: A Scoping Review
by: Borbón A, et al.
Published: (2025-01-01)

Pharmacogenomic profiling of variants affecting efficacy and toxicity of anti-infective medicines in a south Asian population from Sri Lanka
by: Priyanga Ranasinghe, et al.
Published: (2025-02-01)

Discussion on the optimization of personalized medication using information systems based on pharmacogenomics: an example using colorectal cancer
by: Mengying Yuan, et al.
Published: (2025-01-01)

Integrating pharmacogenomics and cheminformatics with diverse disease phenotypes for cell type-guided drug discovery
by: Arda Halu, et al.
Published: (2025-01-01)

Bridging the gap: understanding the perspective of healthcare professional students towards precision medicine in a Nigerian tertiary institution (a cross-sectional study)
by: Ezinwanne Jane Ugochukwu, et al.
Published: (2025-01-01)

Systematic analysis of the pharmacogenomics landscape towards clinical implementation of precision therapeutics in Greece
by: George P. Patrinos, et al.
Published: (2025-02-01)

Decision-making and role preferences for receiving individual pharmacogenomic research results among participants at a Ugandan HIV research institute
by: Sylvia Nabukenya, et al.
Published: (2025-02-01)

CYP2C19 Genotype‐Guided Antiplatelet Therapy and Clinical Outcomes in Patients Undergoing a Neurointerventional Procedure
by: Kayla R. Tunehag, et al.
Published: (2025-01-01)

How data science and AI-based technologies impact genomics
by: Jing Lin, et al.
Published: (2023-01-01)

Impact of crack cocaine on salivary nucleic acids, enzymes, esters, and lipids: A fourier-transform infrared spectroscopy study
by: Gabriela Ribeiro Zucco, et al.
Published: (2025-01-01)

Stem cell therapy for the treatment of psychiatric disorders: a real hope for the next decades
by: Rosa Villanueva
Published: (2025-01-01)

NEK4: prediction of available drug targets and common genetic linkages in bipolar disorder and major depressive disorder
by: Bin Gong, et al.
Published: (2025-01-01)

Integrated treatment of depression and moderate to severe alcohol use disorder in women shows promise in routine alcohol use disorder care – a pilot study
by: Anna Persson, et al.
Published: (2025-02-01)

A prospective hospital-based study on C-reactive protein as a response predictor of antidepressant treatment in drug naïve patients with major depressive disorder
by: Didakamiwan Khonglah, et al.
Published: (2023-04-01)

The Effect of Child Abuse on University Student’s Psychological Status: A Retrospective study
by: Pary M. Azize, et al.
Published: (2018-09-01)

The Drug-Trafficking Economy and Its Dynamics in Latin America
by: Daniel Pontón C.
Published: (2013-09-01)

Impairment of cocaine-mediated behaviours in mice by clinically relevant Ras-ERK inhibitors
by: Alessandro Papale, et al.
Published: (2016-08-01)

A Comparison of Sexual Dysfunctions in Female Patients with Major Depressive Disorder and Panic Disorder
by: Tonguç Demir Berkol, et al.
Published: (2014-08-01)

Neurotrophin-3 as a mediator in the link between PM2.5 exposure and psychiatric disorders: A Mendelian randomization study
by: Yuan Zhang, et al.
Published: (2025-01-01)

SOCIAL ATTITUDES TO DRUGS ABUSE AMONG YOUTH AND DRUG ABUSE PREVENTION
by: Y. N. Nakhimova, et al.
Published: (2017-07-01)

Geographies of Cocaine: Trajectories of Colombian Women Imprisoned for Drug Trafficking in Ecuador
by: Ana María Cerón Cáceres
Published: (2018-05-01)

The Gut Microbiome Regulates the Psychomotor Effects and Context-Dependent Rewarding Responses to Cocaine in Germ-Free and Antibiotic-Treated Animal Models
by: Andrew D. Winters, et al.
Published: (2025-01-01)

Drug Abuse: perspectives on drugs /
by: Kaplan, Robert, 1925-
Published: (1970)

The effect of zopiclone co-administration on sertraline initial dosage optimization in pediatric major depressive disorder patients based on model-informed precision dosing
by: Xiao Chen, et al.
Published: (2025-01-01)

Association between fasting blood glucose and psychotic symptoms in Chinese patients with first-episode drug-naïve major depressive disorder
by: Xingzhi Xia, et al.
Published: (2025-01-01)

Major Depressive Disorder as a Condition Negatively Impacting Both Mental and Physical Functioning. What to Do When There Is Treatment Resistance?
by: Monika Makar, et al.
Published: (2025-01-01)

Oxidative alterations in exfoliated oral mucosa cells of patients with major depressive disorder
by: Lukas Mendes de Abreu, et al.
Published: (2025-03-01)

Genetic insights into psychotic major depressive disorder: bridging the mood-psychotic disorder spectrumResearch in context
by: Thuy-Dung Nguyen, et al.
Published: (2025-02-01)

Association of inflammation cytokines with cognitive function in first-episode major depressive disorder
by: Yan Qing Xi, et al.
Published: (2025-01-01)

Oxytocin attenuates demand for cocaine in female rats
by: Amy S. Kohtz, et al.
Published: (2025-06-01)